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Purpose: We investigated possible correlations between apparent diŠusion coe‹cient (ADC) values and prognostic factors of breast cancer.
Methods: We retrospectively evaluated 81 patients who underwent magnetic resonance (MR) imaging of the breast and were diagnosed pathologically with invasive ductal carcinoma (IDC) not otherwise speciˆed with invasive foci one cm or larger. We excluded ductal carcinoma in situ and IDC with invasive foci smaller than one cm because small lesions decrease the reliability of signal intensity of diŠusion-weighted imaging (DWI). We also excluded special type cancers. We used t-test to compare the mean ADC values of cancers of Stage pT1 (Ã2 cm) versus pT2 or 3 (À2 cm), cancers with versus without vascular invasion, axillary lymph node (N)-positive versus N-negative cancers, estrogen receptor (ER)-positive versus ER-negative cancers, and progesterone receptor (PgR)-positive versus PgRnegative cancers. We analyzed correlations between the ADC value with nuclear grade (NG) and human epidermal growth factor receptor 2 (HER2) score by rank test using Spearman's correlation coe‹cient.
Results: The mean ADC value was signiˆcantly higher for N-positive (n＝28; 0.97±0.20 ×10 -3 mm 2 /s) than N-negative cancers (n＝53; 0.87±0.17×10 
Introduction
Prognostic risk factors in patients with breast cancer are axillary lymph node (N)-positive status, larger tumor size (À2 cm), high nuclear grade (NG), presence of peritumoral vascular invasion, overexpression of human epidermal growth factor receptor type 2 (HER2), and younger age (º35). 1 In addition, N status greatly in‰uences choice of operative procedure (sentinel lymph node biopsy [SLNB] or axillary dissection [Ax] ) and the decision to administer neoadjuvant chemotherapy. Hormone receptor and HER2 expressions are also im-portant factors in choosing treatment. Although some authors have correlated these factors witĥ ndings of dynamic magnetic resonance (MR) imaging, 2-5 we believe only a few studies have reported correlations with apparent diŠusion coe‹cient (ADC) value.
Many reports have described the usefulness of both diŠusion-weighted MR imaging (DWI) and ADC value for evaluating primary breast lesions. [6] [7] [8] [9] [10] DWI is now widely used in routine clinical MR imaging studies. However, DWI and ADC value have been used mainly to diŠerentiate benign and malignant lesions; only a few reports address correlations between ADC value and prognostic factors.
We therefore investigated possible correlations between ADC values and prognostic factors of breast cancer.
Materials and Methods

Patients
Our institutional committee on clinical study approved this retrospective study, and informed consent was waived. We enrolled 130 consecutive patients who underwent MR imaging of the breast including DWI at our institute between May 1, 2006 and May 31, 2007 who were subsequently proven histopathologically to have breast cancer. We excluded 49 patients, including 25 with ductal carcinoma in situ (DCIS) or invasive ductal carcinoma (IDC) with invasive foci of less than one cm (because of the poor reliability of the signal intensity of the ADC map with slightly low spatial resolution), 13 who received neoadjuvant chemotherapy or endocrine therapy, 6 with special type cancer (mucinous carcinoma, 3; invasive lobular carcinoma, 2; metaplastic carcinoma, 1), 4 patients for whom axillary lymph nodes were not sampled, and one patient with low image quality of DWI. As a result, we included 81 patients with 81 breast cancers with invasive foci of one cm or more in this study. All patients were female and aged 34 to 82 years (mean age, 54.3 years). The numbers of cancers by pathological stage were: pT1, 58 (T1b, 4; T1c, 54); pT2, 22; and pT3, one (Union for International Cancer Control [UICC] 2002). Forty cancers were diagnosed as negative for lymph node metastasis by SLNB and 13, by Ax. The remaining 28 cancers were diagnosed as positive for lymph node metastasis; four underwent only SLNB, 15 underwent SLNB followed by Ax, and nine underwent Ax.
MR imaging
Patients underwent MR imaging in prone position using a 1.5-tesla system (Intera Achieva Nova Dual, Philips Medical Systems, Best, The Netherlands) with body coil. Axial DWIs of both breasts were obtained at b values of 0, 500, and 1000 s/mm 2 with parameters: repetition time (TR), 4600 to 6800 ms; echo time (TE), 51.0 ms; number of excitations (NEX) 2; ‰ip angle, 909 ;ˆeld of view (FOV), 360× 360 mm; matrix, 128×88; slice thickness, 5.0 mm; slice gap, 1.5 mm. Fat suppression was applied using a spectral attenuated inversion recovery (SPAIR) technique. ADC maps were automatically generated on the operating console by the methods of least squares using all 3 images with b values of 0, 500 and 1000 s/mm 2 . We placed regions of interest (ROI), maximum-sized circles, within the primary lesions on the ADC maps and obtained ADC values, avoiding apparent necrotic or cystic components by referring to other MR images. Figures 1 to  3 show representative MR images.
Histopathologic assessment
Nuclear grade was classiˆed according to the General Rules for Clinical and Pathological Recording of Breast Cancer 2005. 11 We assessed ER and PgR using mouse monoclonal antibody (Dako, Glostrup, Denmark). We deˆned receptor status using the Allred score, with a total score of 3 or more considered positive. 12 The HER2 score was analyzed by immunohistochemistry using the Hercep Test (Dako, Glostrup, Denmark).
Statistical analysis
We used t-test to compare the mean ADC values of Stage pT1 (Ã2 cm) versus pT2 or 3 (À2 cm) cancers, cancers with versus those without vascular invasion, N-positive versus N-negative cancers, ER-positive versus ER-negative cancers, and PgRpositive versus PgR-negative cancers. We analyzed correlations between the ADC value with NG and the HER2 score by rank test using Spearman's correlation coe‹cient. We did not analyze age statistically because all patients but one were at least 35 years old. For multivariate analysis, we used multiple linear regression to assess factors that showed signiˆcant diŠerences in the univariate analysis. PÃ0.05 was considered statistically signiˆcant. Statistical analyses were performed using Statcel (OMS, Tokorozawa, Japan).
Results
Univariate analysis demonstrated signiˆcantly higher mean ADC value for N-positive (0.97±0.20 ×10 -3 mm 2 /s; n＝28) than N-negative cancers (0.87±0.17×10 -3 mm 2 /s; n＝53) (P＝0.017) (Fig.  4) ; signiˆcantly lower mean ADC value for ERpositive (0.88±0.15×10 -3 mm 2 /s; n＝63) than ER-negative cancers (1.01±0.21×10 -3 mm 2 /s; n＝18) (P＝0.005) (Fig. 5) T. Kamitani et al.
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with score of 3＋(n＝14). The HER2 score also showed no signiˆcant correlation with ADC. In the multivariate analysis, only N and ER were signiˆcant (Table) .
Discussion
The inverse correlation of tumor ADC values with tumor cellularity has been reported. 6, 7 In this study, we observed higher ADC values for N-positive than N-negative cancers, and we speculate that the high ADC values in N-positive cancers may be attributable to a relatively large number of micronecroses orˆbroses. The presence ofˆbrotic focus or necrosis is an important clinicopathological parameter associated with a higher degree of malignancy in IDCs. [13] [14] [15] [16] One study reported signiˆcant association between the presence of nodal metasta- sis and the presence ofˆbrotic focus. 17 King and associates contended that ADC value increased as the amount of necrosis increased and that areas of micronecrosis also contribute to the ADC value. 18 Theseˆndings support our results. Though we avoided apparent necrotic or cystic components, micronecrosis that was visually imperceptible by other sequences may have aŠected the ADC.
However, Kim and colleagues reported no correlation between ADC value and the presence of lymph node metastasis. 19 One reason our results diŠer may be because they included special type breast cancers other than IDC, but we excluded such special types. For example, mucinous carcinomas show higher ADC values than IDC, 7, 20 but lymph node metastasis of mucinous carcinoma of the breast is rare. 21 DiŠerences in tumor size might also aŠect the results, but Kim's group did not detail tumor size. We excluded patients with DCIS or IDC with invasive foci smaller than one cm because we thought the signal intensity of small lesions was unreliable on the ADC maps with the low resolution. In addition, the larger size of our study population than Kim's might account for the signiˆcant diŠerence between our studyˆndings.
In contrast, Razek and colleagues reported the opposite result. 22 They associated lower ADC values with the presence of axillary lymph nodes metastasis. These disparate results may be explained by the diŠerence in study populations because larger tumor size is a risk factor for lymph node metastasis. Their study included many large (À5 cm) cancers, whereas the number of large cancers in our study was small because we excluded patients who had received neoadjuvant chemotherapy or endocrine therapy.
We observed lower ADC values for ER-positive than ER-negative cancers. Other authors reporting the same result 19, [23] [24] [25] have inferred that ER inhibited the angiogenic pathway and induced a decrease in perfusion, thus aŠecting the ADC value. In addition, ER-positive tumors have shown high cellularity. [26] [27] [28] These results also support ourˆnding of lower ADC values of ER-positive cancers. Despite a signiˆcant diŠerence in the univariate analysis, PgR positivity and negativity showed no signiˆcant diŠerence in the multivariate analysis. ER appears to have been the confounding factor that in‰uenced PgR in the univariate analysis because it is known that most ER-positive cancers are also PgR-positive, and this applied to our series.
In this study, we did not analyze the prognosis itself, but prognostic factors. Further study evaluating recurrence or survival rate by long-term followup is required to clarify prognoses.
Our study has several limitations. Because SLNB has been reported to yield some false negatives, [29] [30] [31] some of our patients with lymph node metastasis may have been judged negative for metastasis based on their assessment by SLNB alone. Secondly, we did not include ‰uorescence in situ hybridization (FISH) analysis in this study for HER2 evaluation because it was not performed in some patients in the early period. According to recent guidelines, FISH analysis should be performed when the score is 2＋ at immunohistochemistry. However, we believe this did not likely signiˆcantly in‰uence our results because there were only minor diŠerences among ADCs of 0, 1＋, and 3＋.
Conclusion ADC values were signiˆcantly higher for N-positive than N-negative breast cancers and signiˆcant-ly lower for ER-positive than ER-negative breast cancers.
